Get the Stockscreener App
1.20
0.00%
0.00
Pre-market:
1.20
Rapt Therapeutics Inc Stock (RAPT) Forecast
The Rapt Therapeutics Inc (RAPT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $23.05, representing a +1,821% increase from the current price of $1.20. The highest analyst price target is $25.89, and the lowest is $20.21.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RAPT Price Target
Average 23.82
(+1,885% Upside)
Is Rapt Therapeutics Inc (RAPT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.92 | Neutral |
| STOCH(9,6) | 15.13 | Buy |
| STOCHRSI(14) | 18.80 | Buy |
| MACD(12,26) | -0.0364 | Sell |
| ADX(14) | 25.06 | Buy |
| William %R | -81.25 | Buy |
| CCI(14) | -47.61 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.319
Sell
|
1.2815
Sell
|
| MA20 |
1.4147
Sell
|
1.3217
Sell
|
| MA50 |
1.3576
Sell
|
1.4301
Sell
|
| MA100 |
1.6496
Sell
|
1.9772
Sell
|
| MA200 |
3.0929
Sell
|
4.5707
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RAPT could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on RAPT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.92 indicates that RAPT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 15.13 indicates that RAPT is oversold. This indicates that RAPT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 18.8 indicates that RAPT is oversold. This suggests that RAPT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.06 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -47.61 indicates that RAPT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RAPT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Rapt Therapeutics Inc financial reports and earnings history, Rapt Therapeutics Inc (RAPT) stock could reach $8.625 by 2030, $26.14 by 2040 and $6.8994 by 2050. See the projected annual prices until 2050 of the Rapt Therapeutics Inc stock below:
- Rapt Therapeutics Inc (RAPT) is expected to reach an average price of $3.2521 in 2035, with a high prediction of $7.7619 and a low estimate of $0.5282. This indicates an $171.01% rise from the last recorded price of $1.20.
- Rapt Therapeutics Inc (RAPT) stock is projected to chart a bullish course in 2040, with an average price target of $0.9987, representing an $-16.78% surge from its current level. The forecast ranges from a conservative $0.2713 to a sky-high $26.14.
- Our analysts predict Rapt Therapeutics Inc (RAPT) to jump 1,877% by 2045, soaring from $2.2447 to an average price of $23.73, potentially reaching $25.40. While $2.2447 is the low estimate, the potential upside is significant.
- Rapt Therapeutics Inc (RAPT) stock is expected to climb by 2050, reaching an average of $4.9189, a $309.91% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.8994 and $7.487, respectively, highlighting the market's uncertainty.
Rapt Therapeutics Inc Stock (RAPT) Year by Year Forecast
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2025
Rapt Therapeutics Inc Stock (RAPT) is expected to reach an average price of $23.82 in 2025, with a high prediction of $37.42 and a low estimate of $10.22. This indicates an +1,885% rise from the last recorded price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $22.75 | $20.21 | $25.89 | +1,796% |
| March, 2025 | $20.92 | $16.55 | $24.43 | +1,643% |
| April, 2025 | $31.03 | $18.05 | $33.80 | +2,486% |
| May, 2025 | $26.33 | $22.32 | $33.81 | +2,094% |
| June, 2025 | $24.31 | $23.44 | $37.42 | +1,926% |
| July, 2025 | $17.26 | $10.22 | $30.96 | +1,338% |
| August, 2025 | $17.05 | $15.98 | $21.45 | +1,320% |
| September, 2025 | $16.59 | $14.34 | $17.64 | +1,283% |
| October, 2025 | $13.85 | $13.71 | $17.83 | +1,054% |
| November, 2025 | $17.55 | $10.59 | $20.72 | +1,363% |
| December, 2025 | $16.61 | $14.78 | $19.55 | +1,284% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2026
The predicted value for Rapt Therapeutics Inc (RAPT) in 2026 is set at an average of $25.63. Estimates vary from a peak of $39.07 to a trough of $12.18, indicating an +2,036% surge from the present price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.46 | $13.45 | $18.98 | +1,105% |
| February, 2026 | $30.38 | $13.11 | $39.07 | +2,432% |
| March, 2026 | $29.57 | $25.85 | $32.40 | +2,364% |
| April, 2026 | $27.97 | $24.92 | $30.04 | +2,231% |
| May, 2026 | $31.91 | $25.07 | $32.38 | +2,559% |
| June, 2026 | $26.91 | $26.39 | $36.58 | +2,143% |
| July, 2026 | $27.53 | $25.23 | $29.31 | +2,194% |
| August, 2026 | $27.14 | $26.10 | $35.86 | +2,162% |
| September, 2026 | $32.64 | $24.56 | $32.90 | +2,620% |
| October, 2026 | $17.04 | $16.01 | $36.77 | +1,320% |
| November, 2026 | $17.86 | $14.74 | $20.52 | +1,388% |
| December, 2026 | $20.09 | $12.18 | $21.10 | +1,574% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Rapt Therapeutics Inc (RAPT) is $17.38, with a high forecast of $28.73 and a low forecast of $6.0256. This indicates an +1,348% increase from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.97 | $16.62 | $20.59 | +1,481% |
| February, 2027 | $11.29 | $10.93 | $20.74 | +840.60% |
| March, 2027 | $10.91 | $6.0256 | $12.08 | +809.22% |
| April, 2027 | $15.41 | $9.5208 | $15.90 | +1,184% |
| May, 2027 | $17.13 | $13.38 | $18.48 | +1,328% |
| June, 2027 | $22.97 | $13.54 | $26.45 | +1,814% |
| July, 2027 | $22.48 | $18.85 | $28.73 | +1,774% |
| August, 2027 | $18.88 | $17.93 | $24.07 | +1,473% |
| September, 2027 | $16.81 | $16.03 | $19.98 | +1,301% |
| October, 2027 | $14.07 | $13.32 | $21.02 | +1,073% |
| November, 2027 | $13.58 | $11.99 | $15.59 | +1,032% |
| December, 2027 | $24.41 | $13.03 | $27.11 | +1,934% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2028
In 2028, Rapt Therapeutics Inc (RAPT) is projected to reach an average price of $17.59, with a high projection of $27.95 and a low estimate of $7.2363. This indicates an +1,366% rise from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $26.06 | $22.59 | $26.83 | +2,072% |
| February, 2028 | $21.21 | $20.60 | $27.95 | +1,667% |
| March, 2028 | $13.31 | $12.32 | $23.27 | +1,009% |
| April, 2028 | $15.55 | $13.82 | $17.25 | +1,195% |
| May, 2028 | $17.21 | $15.62 | $18.43 | +1,334% |
| June, 2028 | $16.34 | $14.81 | $18.71 | +1,261% |
| July, 2028 | $20.55 | $16.31 | $21.34 | +1,613% |
| August, 2028 | $15.79 | $14.77 | $22.45 | +1,215% |
| September, 2028 | $13.95 | $13.89 | $17.70 | +1,063% |
| October, 2028 | $8.1495 | $7.7795 | $14.48 | +579.13% |
| November, 2028 | $10.91 | $7.2363 | $13.08 | +809.42% |
| December, 2028 | $14.28 | $9.9764 | $15.03 | +1,090% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2029
The 2029 price forecast for Rapt Therapeutics Inc Stock (RAPT) is $21.47 on average, with a high prediction of $41.77 and a low estimate of $1.1745. This represents an +1,689% increase from the previous price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $20.91 | $13.42 | $22.95 | +1,643% |
| February, 2029 | $21.78 | $19.77 | $23.15 | +1,715% |
| March, 2029 | $5.4568 | $3.7401 | $24.22 | +354.73% |
| April, 2029 | $5.2436 | $4.7369 | $6.9502 | +336.96% |
| May, 2029 | $5.047 | $4.467 | $6.5872 | +320.59% |
| June, 2029 | $3.0734 | $2.21 | $5.4904 | +156.12% |
| July, 2029 | $16.34 | $2.5068 | $32.39 | +1,261% |
| August, 2029 | $18.10 | $11.45 | $26.38 | +1,409% |
| September, 2029 | $32.56 | $17.10 | $39.59 | +2,613% |
| October, 2029 | $10.38 | $9.1143 | $41.77 | +765.36% |
| November, 2029 | $10.23 | $1.1745 | $13.50 | +752.32% |
| December, 2029 | $6.6214 | $5.2147 | $12.42 | +451.79% |
Rapt Therapeutics Inc Stock (RAPT) Price Forecast for 2030
Rapt Therapeutics Inc Stock (RAPT) is expected to reach an average price of $18.55 in 2030, with a high forecast of $32.98 and a low forecast of $4.1166. This signifies an +1,446% surge from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.3684 | $4.1166 | $8.625 | +430.70% |
| February, 2030 | $12.36 | $6.4018 | $15.24 | +930.16% |
| March, 2030 | $18.95 | $11.68 | $26.17 | +1,479% |
| April, 2030 | $12.55 | $12.21 | $21.35 | +945.75% |
| May, 2030 | $17.62 | $12.03 | $19.49 | +1,368% |
| June, 2030 | $19.82 | $16.36 | $29.35 | +1,552% |
| July, 2030 | $24.15 | $17.86 | $32.98 | +1,912% |
| August, 2030 | $7.95 | $5.82 | $26.55 | +562.50% |
| September, 2030 | $14.66 | $8.2034 | $17.07 | +1,122% |
| October, 2030 | $12.22 | $9.9801 | $16.51 | +918.37% |
| November, 2030 | $13.31 | $10.37 | $13.34 | +1,009% |
| December, 2030 | $13.71 | $6.2942 | $14.83 | +1,042% |
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):